Citation sources

Updated weekly. Details via Crossref
Crossref Scopus Google Scholar
17 16 Search
2025
Management of Hepatitis B virus infection in patients on treatment with immunosuppressants or immunomodulators: Position Paper of Associazione Italiana Studio del Fegato (AISF), Associazione Italiana di Oncologia Medica (AIOM), Gruppo Italiano per il Trapianto di Midollo Osseo (GITMO), Società Italiana di Reumatologia (SIR), Società Italiana Trapianti d'Organo (SITO), Società Italiana di Gastroenterologia (SIGE), Società Italiana di Malattie Infettive e Tropicali (SIMIT)
Digestive and Liver Disease
2025
Delayed Hepatitis B Virus Reactivation at 33 Months after the Completion of Rituximab-based Chemotherapy
Internal Medicine
2024
ÇÖZÜLMÜŞ HEPATİT B ENFEKSİYONLU VE ROMATİZMAL HASTALIĞI OLAN BİREYLERDE RİTUKSİMAB KULLANIMININ HEPATİT B REAKTİVASYONU ÜZERİNE ETKİSİ: TEK MERKEZLİ BİR ÇALIŞMA
İnönü Üniversitesi Sağlık Hizmetleri Meslek Yüksek Okulu Dergisi
2023
Frequency of B-Cell Subpopulations in Low Responders in Comparison with High Responders to Hepatitis B Vaccine Among Health Care Workers
Current Microbiology
2023
Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies in the targeted therapy era
World Journal of Gastroenterology
2022
Risk of HBV reactivation in relapsed or refractory diffuse large B-cell lymphoma patients receiving Bruton tyrosine kinase inhibitors therapy
Frontiers in Immunology
2022
Significance of anti‐HBc serological status in primary immune thrombocytopenia
British Journal of Haematology
2022
A case report of hepatitis B virus reactivation 19 months after cessation of chemotherapy with rituximab
Frontiers in Immunology
2021
Impact of switching to tenofovir alafenamide fumarate in patients with entecavir-treated chronic hepatitis B
European Journal of Gastroenterology & Hepatology
2021
Liver failure from delayed hepatitis B reactivation in anti-HBc-positive patient following rituximab for B-cell lymphoma
BMJ Case Reports
2021
Clinical and economic evaluation of a surveillance protocol to manage hepatitis B virus (HBV) reactivation among lymphoma patients with resolved HBV infection receiving rituximab
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
2021
Serial changes in FIB‐4 score and hepatocarcinogenesis in hepatitis B patients treated with or without nucleot(s)ide analogue therapy
GastroHep
2021
Management of Hepatitis B Virus Reactivation in Malignant Lymphoma Prior to Immunosuppressive Treatment
Journal of Personalized Medicine
2020
Rituximab-induced autoimmune hepatitis: A case study and literature review
Canadian Liver Journal
2020
Severe acute exacerbation of HCV infection in cancer patients who undergo chemotherapy: Some issues
Journal of Viral Hepatitis
2020
Serological hepatitis B virus (HBV) activity in patients with HBV infection and B‐cell non‐Hodgkin’s lymphoma
European Journal of Haematology
2020
Antineoplastics
Reactions Weekly